{"id":"NCT01470144","sponsor":"Actelion","briefTitle":"Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension","officialTitle":"An Open-label Extension of Study AC-066A301 Investigating the Safety and Tolerability of ACT-385781A in Patients With Pulmonary Arterial Hypertension (PAH)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-06-01","primaryCompletion":"2015-06-01","completion":"2015-07-01","firstPosted":"2011-11-11","resultsPosted":"2016-12-09","lastUpdate":"2025-02-04"},"enrollment":41,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Arterial Hypertension"],"interventions":[{"type":"DRUG","name":"Epoprostenol","otherNames":[]}],"arms":[{"label":"Treatment","type":"EXPERIMENTAL"}],"summary":"This is an open-label, nonrandomized extension to study AC-066A301. The study will assess safety and tolerability of ACT-385781A while providing a means for continuing treatment after ending participation in study AC-066A301.","primaryOutcome":{"measure":"Treatment-emergent Adverse Events","timeFrame":"On average 2.72 years","effectByArm":[{"arm":"Treatment","deltaMin":41,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":41},"commonTop":["Headache","Nasopharyngitis","Diarrhoea","Pain in extremity","Cough"]}}